For biopharmaceutical manufacturing, the greatest current
change is the impact of increasing expression levels on the
volume of capacity that is required for production.
Saturday, January 01, 2011
Many pharmaceutical companies, big and small, have been outsourcing work to contract research organizations (CRO’s) and contract manufacturing organizations (CMO’s).